Owens & Minor Inc

Owens & Minor Inc

Health CareHealth Care Equipment & Services
  • Price (USD)6.27
  • Today's Change-0.42 / -6.28%
  • Shares traded1.81m
  • 1 Year change-16.51%
  • Beta1.4584
Data delayed at least 15 minutes, as of Jan 24 2020 23:30 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Owens & Minor, Inc. is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company operates through three segments, which includes Domestic, International and Proprietary Products. The Company’s domestic segment focuses on United States distribution, logistics and value-added services business. The Company’s International segment focuses on European distribution, logistics and value-added services business. The Company’s proprietary products segment provides product-related solutions, including surgical and procedural kitting and sourcing. The Company provides its services to hospitals, integrated healthcare systems, group purchasing organizations, and the United State federal Government, manufacturers of life-science and medical devices, supplies and pharmaceuticals.

  • Revenue in USD (TTM)9.89bn
  • Net income in USD-285.17m
  • Incorporated1993
  • Employees6.70k
  • Location
    Owens & Minor Inc9120 LOCKWOOD BLVDMECHANICSVILLE 23116United StatesUSA
  • Phone+1 (804) 723-7000
  • Fax+1 (804) 723-7100
  • Websitehttp://www.owens-minor.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
GenMark Diagnostics, Inc80.20m-48.63m310.15m477.00--36.20--3.87-0.8548-0.85481.410.14750.9114.657.90168,140.50-55.23-51.50-71.03-64.0030.8745.61-60.63-100.352.11-9.460.8505--34.7320.8918.35---12.95--
RTI Surgical Holdings Inc299.39m-11.77m321.83m891.00--1.3894.271.07-0.1724-0.16214.054.060.63851.165.95336,019.10-2.510.5315-2.800.63154.4450.68-3.930.70891.320.68780.3606--0.46227.24-184.88---36.45--
Semler Scientific Inc29.58m13.64m326.53m24.0029.5623.1522.9311.041.691.693.702.162.28--10.29--105.33-53.36166.00-356.4088.3179.4946.11-23.20--253.030.00--72.5956.71432.05--13.86--
Zynex Inc.40.65m9.17m331.36m182.0037.3519.9834.368.150.27090.27091.200.50662.145.3511.37223,335.2048.2218.5960.79115.7180.7570.5522.558.563.65--0.012--36.218.0429.69--10.93--
Sientra Inc79.51m-111.20m333.75m101.00--3.47--4.20-3.32-3.322.251.950.39661.193.64306,992.30-55.47-33.38-78.49-45.3960.1266.37-139.86-95.712.32-33.870.3212--86.4314.14-180.35--64.49--
Accuray Incorporated412.53m-16.58m349.87m947.00--8.50--0.8481-0.1879-0.18794.690.46260.99062.064.82435,620.90-3.98-3.57-6.68-6.7138.2338.77-4.02-3.941.200.05990.8214--3.432.54-149.01---18.42--
Stereotaxis Inc29.28m-5.51m356.96m133.00--15.66--12.19-0.0944-0.09440.4970.43070.93054.236.57---12.96-23.81-19.90--80.1274.20-13.92-14.283.26--0.00---5.77-5.0582.00------
SeaSpine Holdings Corp153.37m-40.21m383.25m361.00--2.44--2.50-2.15-,844.90-28.53-28.27-35.92-35.3462.6558.41-26.22-31.811.75--0.00--8.82-0.432642.41--8.51--
Utah Medical Products, Inc.44.83m10.75m385.14m173.0035.974.0523.338.592.883.6812.0025.530.44112.949.39259,121.4010.5815.5511.0416.6661.9261.5023.9931.9611.61--0.0029.951.410.73255.
Alphatec Holdings Inc106.42m-63.93m390.26m195.00--6.69--3.67-1.37-1.372.231.340.68710.98467.70545,733.30-32.57-25.17-41.17-38.2571.2967.25-47.40-38.332.67-3.330.3899---9.87-14.84-831.63---15.48--
Owens & Minor, Inc.9.89bn-285.17m394.08m6.70k--0.8023--0.0399-4.75-4.75164.607.822.567.1612.271,475,759.00-7.39-0.8306-11.48-1.3514.7112.71-2.88-0.25310.84750.88670.7601--5.591.64-1,280.90--1.78-2.29
Meridian Bioscience, Inc.201.01m24.38m408.14m660.0016.772.1311.882.030.56820.56824.684.470.69692.035.92304,566.708.4511.439.1712.5158.8661.8512.1313.495.0330.730.284290.63-5.881.2610.48-6.84-11.52-20.56
Cutera, Inc.175.39m-36.55m414.76m402.00--9.41--2.36-2.62-2.6212.423.101.522.677.21436,283.60-31.76-1.21-56.35-1.7550.2754.91-20.84-0.98351.05-70.390.0279--7.4116.88-182.51--23.54--
TransMedics Group Inc21.09m-32.01m422.22m92.00--6.65--20.02-1.55-1.551.023.000.2620.93964.07229,250.00-39.75---47.41--55.10---151.75--6.61-6.550.349--69.38---14.09------
Oxford Immunotec Global PLC70.96m32.96m440.34m236.0014.142.0612.576.,919.1017.91-10.9922.09-12.7072.7861.5246.45-24.6812.65--0.0001--9.179.03205.74--24.22--
Viewray Inc91.98m-101.73m466.59m221.00--2.92--5.07-1.05-1.050.94511.090.34121.683.29416,181.00-37.74-63.61-46.06-109.53-1.031.56-110.60-180.492.49-31.840.3396--137.8391.31-9.63--16.76--
Data as of Jan 24 2020. Currency figures normalised to Owens & Minor Inc's reporting currency: US Dollar USD

Institutional shareholders

52.47%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 20199.02m14.35%
Dimensional Fund Advisors LPas of 30 Sep 20195.05m8.03%
The Vanguard Group, Inc.as of 30 Sep 20195.04m8.02%
JPMorgan Investment Management, Inc.as of 30 Sep 20193.94m6.27%
SSgA Funds Management, Inc.as of 30 Sep 20192.25m3.58%
Royce & Associates LPas of 30 Sep 20192.01m3.20%
GSO Capital Partners LPas of 30 Sep 20191.76m2.80%
Invesco Capital Management LLCas of 30 Sep 20191.35m2.15%
LSV Asset Managementas of 30 Sep 20191.30m2.07%
Renaissance Technologies LLCas of 30 Sep 20191.25m1.99%
More ▼
Data from 30 Sep 2019 - 30 Sep 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.